Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

NCT06933329 is registered in ClinicalTrials.gov with BicycleTx Limited as lead sponsor.

NCT NCT06933329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06933329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
Lead sponsor
BicycleTx Limited
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 18, 2025
Completion date
February 28, 2029
Enrollment
73 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer